Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Choosing Wisely: Evaluating Latent Factor Models in the Presence of a Contaminated Instrumental Variable with Varying Strength 0 0 1 1 3 4 33 35
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 0 1 48 6 19 52 135
Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California 0 1 5 15 2 9 22 36
Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies 0 0 0 5 6 8 17 31
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 0 1 48 1 4 24 198
Estimating Lifetime or Episode-of-illness Costs 0 1 2 110 0 3 11 296
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 52 0 2 5 159
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 18 2 3 12 110
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 39 5 7 15 202
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 290 3 4 11 883
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 1 47 1 6 12 172
Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics 0 0 0 16 2 5 8 29
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 0 0 0 86 4 6 20 174
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 0 16 4 5 7 44
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 0 1 63 3 4 18 112
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 1 1 1 51 5 7 13 47
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 0 7 3 6 29 79
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 0 57 2 4 10 238
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 0 73 2 4 11 113
The Role of Physician Altruism in the Physician-Industry Relationship 0 0 2 12 4 5 15 29
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 0 0 42 1 4 6 107
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 42 1 1 9 171
Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors 0 0 0 21 2 4 12 62
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 0 54 4 5 10 228
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 0 0 1 484 3 4 16 1,357
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 1 147 3 3 13 533
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 36 1 1 8 63
Total Working Papers 1 3 17 1,880 73 137 419 5,643


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 3 1 1 6 30
Comparing alternative models: log vs Cox proportional hazard? 0 0 0 148 3 4 11 581
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 2 3 12 327
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 6 1 2 10 52
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 29 2 4 14 259
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 1 2 7 53
Estimating lifetime or episode‐of‐illness costs under censoring 0 0 2 23 3 6 20 101
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 0 1 145 2 3 8 427
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 0 143 2 3 7 365
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 0 2 8 32
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 0 1 105 4 5 17 304
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 0 72 3 4 18 202
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 5 0 1 1 15
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 0 2 40 1 2 8 158
Personalized Medicine in the Context of Comparative Effectiveness Research 0 0 0 13 0 3 8 110
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 2 3 7 54
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 10 12 14 32
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 1 1 1 53 3 4 7 224
The impact of comparative effectiveness research on health and health care spending 0 0 0 35 4 7 13 288
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 2 3 13 935 7 29 94 2,794
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 2 3 9 43
Total Journal Articles 3 4 20 1,780 53 103 299 6,451


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 2 28 6 9 23 259
Total Software Items 0 0 2 28 6 9 23 259


Statistics updated 2026-05-06